Contribute to Drug Discovery Success by Integrating Compound Management, Analytical and Automation Workflows

Drug Discovery Materials Management has become a science in itself. Driven by the need to supply quality compounds efficiently to scientists on a multi-site, often global basis, CM has over the years in most organizations become a robust, automated and reliable function in Discovery.

So - what's next?

• Unsolved automation challenges - biological samples and discovery materials present many issues; companies are faced integration of multi vendors equipment; and what does a company do when hardware becomes obsolete?
• Sample data management - Much work is still to be done in integrating all information related one sample; extracting relevant data and conducting meta data analysis.
• Managing R&D biomaterials and samples - What will CM's responsibilities be in the future world of biotherapeutics?
• Enhancement of Academic Compound Management and Screening - many institutions are still gearing up, implementing automated systems and building libraries. But most importantly - how can academic/industry collaborative efforts advance drug discovery?
• Complex compound and sample management operations for growing global companies - how to set up CM to support various functions, prioritise jobs, and track and ship compounds global worldwide